Mannosylated PLP(139-151) induces peptide-specific tolerance to experimental autoimmune encephalomyelitis

Area of Science:

• Immunology
• Neuroscience
• Autoimmunity

Background:

• Experimental autoimmune encephalomyelitis (EAE) is a model for multiple sclerosis.
• Myelin proteolipid protein (PLP(139-151)) is a key encephalitogenic peptide.
• Mannosylation of antigens can alter immune responses.

Purpose of the Study:

• To investigate the immunomodulatory effects of mannosylated PLP(139-151) (M-PLP(139-151)) in EAE.
• To determine the mechanism by which M-PLP(139-151) influences EAE development and T cell responses.

Main Methods:

• SJL mice were immunized with M-PLP(139-151) in complete adjuvant.
• Assessed EAE development, central nervous system (CNS) mononuclear cell infiltration, and delayed-type hypersensitivity.
• Measured T cell proliferation and peptide-specific IgG2a antibody responses after re-immunization.

Main Results:

• M-PLP(139-151) immunization prevented EAE development and reduced CNS infiltration.
• Despite normal T cell responses to other peptides, M-PLP(139-151)-immunized mice showed impaired delayed-type hypersensitivity to PLP(139-151).
• Re-immunization led to tolerance to EAE, reduced T cell proliferation, and decreased IgG2a levels.

Conclusions:

• M-PLP(139-151) induces peptide-specific tolerance to EAE.
• The mechanism likely involves deletion or impaired migration of encephalitogenic T cells.
• Mannosylation represents a potential strategy for inducing immune tolerance in autoimmune diseases.